Important Update

Statement regarding Aethlon’s position with respect to the potential for use of the Hemopurifier as a countermeasure against the current coronavirus SARS-CoV-2 (COVID-19) outbreak

Recent News

March 24, 2020

Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer

February 24, 2020

Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical Stock Expires

View All News

Recent Events

Feb 10, 2020 • 4:30pm EDT

Third Quarter 2020 Investor Call

Nov 1, 2019 • 4:30pm EDT

Second Quarter 2020 Investor Call

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up